Kemal Ener

Kemal Ener

Auto-generated profile, based on publicly available information

Kemal Ener

Department of Urology, Ankara Ataturk Training and Research Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2016 in Andrologia
Verified
Journal Article
Closed access
PDF file
KEK. Ener
K. Ener
MAM. Aldemir
M. Aldemir
EIE. Işık
E. Işık
EOE. Okulu
E. Okulu
MÖM. F. Özcan
M. F. Özcan
AÖA. Özayar
A. Özayar
In this study, we aimed to investigate the impact of vitamin E supplementation on semen parameters and pregnancy after varicocelectomy. Forty-five infertile male patients who were diagnosed with varicocele and underwent subinguinal varicocelectomy were included in the study. After performing subinguinal varicocelectomy, the patients were randomised into two groups: 22 receiving vitamin E for 12 months, and 23 as the control group without receiving any supplementation. The pre-operative parameters of semen analyses and pregnancy rates of both groups were compared with those of post-operative parameters. There were no statistically significant differences between the groups in terms of sperm count and motile sperm percentage, in pre-operative, post-operative 3rd month, post-operative 6th month and post-operative 12th month periods. Repeated-measures anova was performed, and sperm count, percentage of change in sperm count, motile sperm count and percentage of change in motile sperm count of the groups were compared. The administration of vitamin E increased all of these parameters; however, they were not found to be statistically significant. In conclusion, vitamin E supplementation might improve the sperm parameters after varicocelectomy; however, further studies including larger number of samples are needed to make a proper decision on vitamin E supplementation after varicocelectomy.

1 July 2009 in Journal of Endourology
Verified
Journal Article
Closed access
KEKemal Ener
Kemal Ener
KAKoray Agras
Koray Agras
MAMustafa Aldemir
Mustafa Aldemir
EOEmrah Okulu
Emrah Okulu
OKOnder Kayigil
Onder Kayigil
Purpose: Endoscopic treatment of large bladder stones via cystoscope is still bothersome, and open cystolithotomy is the preferred method in many centers. To gain more insight into the endoscopic bladder stone management, we aimed to compare the transurethral use of nephroscope and cystoscope randomly. Patients and Methods: Forty-three male patients with bladder stones were randomized into two groups, to perform nephroscopic (group 1, n = 22) and cystoscopic (group 2, n = 21) stone fragmentation procedures transurethrally. Combined pneumatic/ultrasonic lithotripsy device was used in both groups to fragment the bladder stones. Results: The mean stone size in group 1 and group 2 was 3.6 ± 1.3 cm and 3.5 ± 1.6 cm, respectively (p > 0.05). Stone fragments were removed completely in all of the patients, and the mean operation time was calculated as 48.2 ± 13.2 minutes in group 1 and 68.1 ± 22.7 minutes in group 2, with no intraoperative complications (p < 0.01). None of the patients developed urethral stricture disease in the early (postoperative third month) follow-up. Three patients with previously known urethral stricture disease have shown to have the same disease in the late (postoperative 14.4 ± 5.1 months) follow-up. Conclusion: Treatment of large bladder stones by transurethrally placed nephroscope is a fast and effective treatment modality compared to endoscopic treatment via cystoscope. Nephroscope allows for use of larger forceps and facilitates collection of large stone fragments through its 24F sheath. It also prevents multiple entries to the urethra and hence avoids possible urethral injury. Combined pneumatic/ultrasonic lithotripsy device, with its aspiration quality, enables the surgeon to gain a better endoscopic view during both procedures.

7 June 2015 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
KEKemal Ener
Kemal Ener
MKMurat Keske
Murat Keske
MAMustafa Aldemir
Mustafa Aldemir
MÖMuhammet Fuat Özcan
Muhammet Fuat Özcan
EOEmrah Okulu
Emrah Okulu
ÖEÖzcan Erel
Özcan Erel

1 January 2016 in Urology Research and Practice
Verified
Journal Article
Closed access
KEKemal Ener
Kemal Ener
ACAbdullah Erdem Canda
Abdullah Erdem Canda
SASerkan Altınova
Serkan Altınova
AAAli Fuat Atmaca
Ali Fuat Atmaca
EAErdal Alkan
Erdal Alkan
MBMevlana Derya Balbay
Mevlana Derya Balbay
Objective: In this study we aimed to compare renal functions in patients who underwent robotic partial nephrectomy (RPN) with on-clamp and zero- ischemia techniques. Material and methods: Between 2009 and 2015, 12 off-clamp and 22 on-clamp RPN procedures were performed on a total of 34 patients in two centers. The main outcome parameters examined were serum creatinine, and estimated glomerular filtration rate (eGFR) during preoperative, immediate postoperative periods, and at postoperative 3rd months. Results: There were no statistically significant differences between on-clamp and zero- ischemia groups regarding age, ASA score, BMI, PADUA and R.E.N.A.L. nephrometry scores, operation time and tumor size (p>0.05). Significant differences were found in the duration of hospital stay (3.8±0.9 days vs. 3.0±0.9 days) and amount of blood loss (85.9±49.6 mL vs. 183.3±176.2 mL) between the on-clamp and zero-ischemia groups (p<0.05). Statistically significant differences were found between preoperative and immediate post-operative periods, in terms of eGFR and serum creatinine levels in both groups. Moreover, statistically significant differences were found between preoperative and postoperative 3rd month periods, in the on-clamp group in terms of eGFR and serum creatinine levels. In the zero-ischemia group, the decrease in eGFR and serum creatinine levels at postoperative 3rd month relative to the preoperative period was not statistically significant. Conclusion: Off-clamp RPN technique is superior, in short-term outcomes involving renal functions, compared to on clamp approach. However, long- term data regarding the renal functions should be evaluated to arrive at a definitive decision.

31 October 2015 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
KEKemal Ener
Kemal Ener
ACAbdullah Erdem Canda
Abdullah Erdem Canda
SASerkan Altinova
Serkan Altinova
AAAli Fuat Atmaca
Ali Fuat Atmaca
EAErdal Alkan
Erdal Alkan
MBMevlana Derya Balbay
Mevlana Derya Balbay
The aim of this study was to evaluate outcomes of robotic partial nephrectomy (RAPN) procedures. At two centers, 42 patients underwent RAPN. Radius, Exo/Endophytic, Nearness, Anterior/Posterior, Location (R.E.N.A.L.) nephrometry and PADUA scores of patients were calculated by computed tomography (CT) or magnetic resonance imaging (MRI). Intra‐ and perioperative (0–30 days) complications were evaluated using modified Clavien classification. A four‐arm da Vinci‐S robotic surgical system was used and outcomes were evaluated retrospectively. Mean age of the patients was 52.3 ± 6.5 years. Mean tumor size was 3.1 ± 1.0 (1.4–6.6) cm. R.E.N.A.L. nephrometry and PADUA scores were 6.0 ± 1.5 and 7.5 ± 0.9, respectively. Mean surgical time was 127.7 ± 18.7 minutes and estimated blood loss was 100 ± 18.1 cc. Mean warm ischemia time was 16.0 ± 8.9 (0–30) minutes. Intraoperative complications did not develop in any patient. Median hospital stay was 3.0 (2–6) days. Except for 17 patients, hilar clamping was performed in 25 patients. Histopathology results included 34 renal cell carcinoma (22 clear cell, 7 chromophobe cell, 4 papillary cell, and 1 clear papillary cell). Oncocytoma (n = 4), adenoma (n = 1), fibroadipose tissue (n = 1), papillary epithelial hyperplasia (n = 1), and chronic pyelonephritis (n = 1) were present. Surgical margins were negative in all patients. During a median follow‐up period of 15.5 ± 10.9 (3–46) months, neither local recurrence nor distant metastasis was detected. In conclusion, RAPN is a safe, minimally invasive surgical approach, with excellent surgical and oncological outcomes in T1 kidney tumors. Zero ischemia off‐clamp RAPN is also safe in selected masses with the advantage of avoiding complete renal ischemia.